V
Ventyx Biosciences, Inc. (VTYX)
NMS – Real Time Price. Currency in USD
14.00
0.00 (0.00%)
At close: Mar 3, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
NMS – Real Time Price. Currency in USD
14.00
0.00 (0.00%)
At close: Mar 3, 2026, 4:00 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 17.86 | 6.05 | 10 | |
| Quick ratio | 17.86 | 5.63 | 10 | |
| Debt to Equity | 0.05 | 0.30 | 9.0 | |
| Debt to Assets | 0.05 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -30K | -470K | -941K | -1M | -1M |
| Operating Income | -67M | -113M | -205M | -148M | -116M |
| Net Income | -84M | -108M | -193M | -135M | -107M |
| EBITDA | -67M | -113M | -205M | -147M | -115M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 10.74 | 4.0 |
| Next quarter | N/A | -5.13 | 1.0 |
| Current year | N/A | 26.57 | 5.5 |
| Next year | N/A | -17.89 | 1.0 |
| Weighted average score | 2.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 15.41 | 15.79 | 17.64 | 9.3 |
| Y/Y | 999 | 35.24 | 36 | 50.49 | 10 |
| 3y average | 999 | -25.81 | 16.59 | -67.21 | 5.3 |
| 5y average | 999 | -165.15 | 16.59 | -172.84 | 5.3 |
| Weighted average score | 7.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $32.0M significantly exceed its total debt $10.0M, ensuring strong financial flexibility
Total current assets $201.1M exceed Total current liabilities $11.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$17.6M limits the company's ability to reinvest or pay down debt